Respiratory involvement in neuromuscular disease

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 14, Issue 1, 2014, Pages 72-75

  Bourke, Stephen C ^a,b  

^a NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DECOMPENSATION; ARTICLE; ASSISTED VENTILATION; BREATHING EXERCISE; BULBAR PARALYSIS; DYSPNEA; HUMAN; LUNG CLEARANCE; LUNG FUNCTION TEST; MUSCLE WEAKNESS; NEUROMUSCULAR DISEASE; REM SLEEP; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RESPIRATORY MUSCLE WEAKNESS; SYMPTOM; VOLUME RECRUITMENT TECHNIQUE;

AMYOTROPHIC LATERAL SCLEROSIS; DUCHENNE MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; NON-INVASIVE VENTILATION; RESPIRATORY MUSCLE WEAKNESS;

AMYOTROPHIC LATERAL SCLEROSIS; GUILLAIN-BARRE SYNDROME; HUMANS; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY, DUCHENNE; NEUROMUSCULAR DISEASES; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MUSCLES;

EID: 84896705050     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.14-1-72     Document Type: Article

References (23)

1. O'Neill CL, Williams TL, Peel ET, et al. Non-invasive ventilation in motor neuron disease: an update of current UK practice. J Neurol Neurosurg Psychiatry 2012;83:371-6.
2. Farrero E, Prats E, Povedano M, et al. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest 2005;127:2132-8.
3. Morgan RK, McNally S, Alexander M, et al. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005;171:269-74.
4. Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain-Barre syndrome. Ann Neurol 2010;67:781-7.
5. Simonds AK, Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 1995;50:604-9.
6. Nugent AM, Smith IE, Snhneerson JM. Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 2002;121:459-64.
7. Mellies U, Stehling F, Dohna-Schwake C, et al. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 2005;64:1465-7.
8. Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscular Disord 2002;12:926-9.
9. Simonds AK, Muntoni F, Heather S, Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998;53:949-52.
10. Vianello A, Bevilacqua M, Salvador V, et al. Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy. Chest 1994;105:445-8.
11. Aboussouan LS, Khan SU, Meeker DP et al. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127:450-3.
12. Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5:140-7.
13. Bourke SC, Bullock RE, Williams TL, et al. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003;61:171-7.
14. Marchese S, Lo Coco D, Lo Coco A. Outcome and attitudes toward home tracheostomy ventilation of consecutive patients: a 10-year experience. Resp Med 2008;102:430-6.
15. Raphael JC, Chevret S, Chastang C, Bouvet F. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Lancet 1994; 343:1600-4.
16. Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005;60:1019-24.
17. Lo Coco D, Marchese S, Pesco MC, et al. Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology 2006;67:761-5.
18. Gay PC, Edmonds LC. Severe hypercapnia after low-flow oxygen therapy in patients with neuromuscular disease and diaphragmatic dysfunction. Mayo Clin Proc 1995;70:327-30.
19. Servera E, Sancho J, Zafra M, et al. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil 2005;84:851-7.
20. O'Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax 2008;63:vi1-68.
21. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9:177-89.
22. Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005;60:1019-24.
23. National Institute for Health and Care Excellence. The use of non-invasive ventilation in the management of motor neurone disease. London: NICE, 2010.